ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice
dc.contributor.author | DiMattio, K. M. | |
dc.contributor.author | Yakovleva, Tatyana | |
dc.contributor.author | Aldrich, Jane V. | |
dc.contributor.author | Cowan, A. | |
dc.contributor.author | Liu-Chen, Lee-Yuan | |
dc.date.accessioned | 2017-02-16T20:38:09Z | |
dc.date.available | 2017-02-16T20:38:09Z | |
dc.date.issued | 2014-03-20 | |
dc.identifier.citation | DiMattio, K. M., Yakovleva, T. V., Aldrich, J. V., Cowan, A., & Liu-Chen, L. Y. (2014). Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neuroscience Letters, 563, 155–159. http://doi.org/10.1016/j.neulet.2014.01.022 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23198 | |
dc.description.abstract | It has been shown previously that norbinaltorphimine (norBNI) and 5΄-guanidinonaltrindole (5΄-GNTI), long-acting kappa opioid receptor (KOPR) antagonists, cause frenzied scratching in mice [1;2]. In the current study, we examined if zyklophin, a short-acting cyclic peptide KOPR antagonist, also elicited scratching behavior. When injected s.c. in the nape of the neck of male Swiss-Webster mice, zyklophin at doses of 0.1, 0.3 and 1 mg/kg induced dose-related hindleg scratching of the neck between 3 and 15 min after injection. Pretreating mice with norBNI (20 mg/kg, i.p.) at 18–20 hr before challenge with zyklophin (0.3 mg/kg) did not markedly affect scratching. Additionally, KOPR −/− mice given 0.3 mg/kg of zyklophin displayed similar levels of scratching as wild-type animals. The absence of KOPR in KOPR −/− mice was confirmed with ex vivo radioligand binding using [3H]U69,593. Taken together, our data suggest that the presence of kappa receptors is not required for the excessive scratching caused by zyklophin. Thus, zyklophin, similar to the structurally different KOPR antagonist 5΄-GNTI, appears to act at other targets to elicit scratching and potentially the sensation of itch. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Itch | en_US |
dc.subject | Scratching | en_US |
dc.subject | Kappa opioid receptor | en_US |
dc.subject | Kappa opioid receptor antagonist | en_US |
dc.subject | Zyklophin | en_US |
dc.title | Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Yakovleva, T.V. | |
kusw.kuauthor | Aldrich, J.V. | |
kusw.kudepartment | Medicinal Chemistry | en_US |
dc.identifier.doi | 10.1016/j.neulet.2014.01.022 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.